microdosing with semaglutide Is “Microdosing” the Future of Personalized Metabolic Care? People are 'microdosing' weight-loss drugs.

The Precision Peptide Genetic Test evaluates variants in GLP1R (rs6923761) and other peptide pathway genes that may help provide context about your predisposition to GI side effects, pain sensitivity, and medication tolerance

Other GLP-1 medications, such as Ozempic (semaglutide) and Mounjaro (tirzepatide), are approved for diabetes but used off-label to help patients lose weight

Key Pharmaceutical and Regulatory Guidelines Compounded semaglutide is not FDA-approved

Further Reading Microdose GLP-1 Low-dose semaglutide or tirzepatide $189/mo Start low and adjust with a licensed provider

Available as a $99 add-on or $298 standalone